FOLLOW US

America September 15, 2026 3 mins read

Electra Therapeutics’ $325M IPO Bets Big on Precision Immune Therapy

America ı By Rihem Akkouche

0 Comments

Electra Therapeutics' $325M IPO

Traditional treatments for immune diseases often work like a wide-net fishing operation — catching everything indiscriminately, damaging good and bad alike. Electra Therapeutics is betting its public debut on a different approach entirely, one built around precision rather than blunt suppression. The biotechnology firm plans to make its Nasdaq debut this week through an estimated $325 million initial public offering, guided by legal teams from Cooley LLP and Latham & Watkins LLP.

The Numbers Behind the Offering

Electra intends to offer 21.7 million shares priced between $14 and $16 apiece, a range expected to raise $325 million at the midpoint, according to a Monday filing with the U.S. Securities and Exchange Commission. At that midpoint valuation, the South San Francisco-based company would command a fully diluted market value of $976.1 million, according to IPO research firm Renaissance Capital — a figure that places Electra firmly in the billion-dollar neighborhood even before its first day of trading.

A Scientific Approach Built on Selectivity

Founded in 2018, Electra has spent years developing antibodies aimed at immune diseases and cancer. Its lead drug candidate is designed to selectively deplete pathological myeloid cells and T cells — essentially targeting the specific cells driving disease while leaving healthy immune function largely untouched, according to the filing.

The Science in the Company's Own Words

Electra described its approach to regulators in striking detail: "Our novel approach targets signal regulatory proteins (SIRP), a family of cell surface receptors whose expression is restricted to specific immune cell populations, and increases upon activation to enable selective depletion of disease-driving cells while preserving normal immune function." The company went further, framing its ambitions in sweeping terms: "By replacing broad immunosuppression with selective elimination of principal cells that drive disease, we believe our approach can do for immune-mediated diseases what precision oncology has done for cancer, transforming the treatment paradigm for patients."

Where the Money Will Go

According to the filing, Electra plans to direct the proceeds from its offering toward advancing its drug candidates through further development, funding additional research and development activities, and covering general working capital needs — the standard playbook for a clinical-stage biotech looking to extend its runway.

Backed by Deep-Pocketed Health Investors

Electra isn't walking into the public markets alone. The company counts health-focused investment firms such as OrbiMed, Westlake BioPartners and Redmile Biopharma Investments among its backers, according to the filing — a roster of specialized investors whose involvement often signals a degree of scientific vetting beyond the ordinary.

The Path to Trading

Electra plans to list on the Nasdaq under the ticker symbol ETRA. The offering is expected to price on or about Thursday, with trading anticipated to begin Friday, according to a Nasdaq calendar — putting the company on track for a swift transition from private biotech to publicly traded company within the same week.

The Legal Team Guiding the Deal

Cooley advised Electra on the offering, with a team that included Charles Bair, Charles Kim, Sara Semnani and Dylan Kornbluth steering the legal side of the transaction.

If Electra's science delivers on its stated ambitions, the company's IPO may mark more than just a fundraising milestone — it could represent an early test of whether precision-targeted immune therapy is ready to follow the same transformative path that precision oncology carved out for cancer treatment years earlier.

Previous Article

Robinhood Engineers Crypto-Futures Insider Charges Reveal Betting on Company Secrets

Read More
4594 Posts

Rihem Akkouche

Rihem Akkouche is a passionate journalist dedicated to shedding light on compelling stories, sparking conversations, and fostering a more informed world.

Discussion

No comments yet. Be the first to join the discussion!

Don’t Miss It
America November 18, 2026 Iran Says It Targeted Kuwaiti Air Base Hosting U.S. Troops By – Michallie K Harrison
America November 18, 2026 China to Lift 25% Tariff on Some Canadian Pork and Seafood as U.S. Auto Talks Drag On By – Michallie K Harrison
America November 18, 2026 WSJ Reports Nvidia SEC Probe After Jensen Huang’s Exit By – Michallie K Harrison
America November 18, 2026
Brazil Probes Whether Vance-Linked Group Aided…

Brazilian federal police are investigating whether Rockbridge Network, a U.S.…

By – Michallie K Harrison
America November 18, 2026
13 U.S. Babies Born With Measles…

U.S. officials documented 13 babies born with measles and 112…

By – Michallie K Harrison
America November 17, 2026
Katie Couric Reveals  Memory-Loss Episode That…

Katie Couric is opening up about a recent frightening medical…

By – Jackie Allen
America November 17, 2026
Kiefer Sutherland Seeks Dismissal and Claims…

LOS ANGELES — Kiefer Sutherland, best known for portraying counterterrorism…

By – Jackie Allen
America November 17, 2026
Russell Brand Wife Publishes His Defiant…

LONDON — Russell Brand is facing an investigation by British…

By – Jackie Allen
America November 17, 2026
Nvidia Executives Have $950M Insurance Protection…

SAN JOSE, Calif. – Nvidia has built one of the…

By – Samuel Lopez
America November 17, 2026
eBay $55.7M Mass. Couple Settlement: Insurer…

The eBay $55.7M Mass. couple settlement has now landed in…

By – Rachel Moore
America November 17, 2026
NSA Classified Internal Network Goes Offline

WASHINGTON — The NSA’s classified internal network, used to store…

By – Jackie Allen
America November 17, 2026
L’Oreal US Settles Hair Relaxer Cancer…

The first jury trial over hair relaxers and cancer ended…

By – Rachel Moore
America November 17, 2026
Global Cyberattack Fears Grow as NSA,…

WASHINGTON – Over the past several weeks, hackers have interfered…

By – Samuel Lopez
America November 17, 2026
Aon completes $17B acquisition of USI

The Aon $17B acquisition of USI has crossed the finish…

By – Rachel Moore
America November 17, 2026
Cyber Attack Today: Hackers Hide Malicious…

The cyber attack today has turned some of the internet’s…

By – Rachel Moore
America November 17, 2026
Apple services, including iCloud and the…

The Apple outage is the latest in a string of…

By – Rachel Moore
America November 17, 2026
classified US national security communications network…

The NSA network down story landed with a jolt. The…

By – Rachel Moore
America November 17, 2026
Microsoft Apologizes After Worldwide Outlook Outage,…

Microsoft has apologized to customers and business partners following a…

By – Jackie Allen
America November 17, 2026
Widespread Technology Disruption in Major Banks,…

NEW YORK — A wave of technology disruption has affected…

By – Jackie Allen
America November 17, 2026
Optimizely Hack Turns Trusted Websites Into…

An Optimizely hack exposed visitors to malicious code through website…

By – Michallie K Harrison
America November 16, 2026
Iran Dirty Bomb Report Sparks U.S.…

WASHINGTON — An Iran dirty bomb report describes U.S. contingency…

By – Michallie K Harrison
America November 17, 2026
“Not the Wild West”: California Sues…

California sues OpenAI, alleging about 700 AI agents hacked Hugging…

By – Derek Johnson
America November 16, 2026
FBI Investigates Explosive Device at Illinois…

PEORIA, Illinois — Federal authorities are investigating an explosive device…

By – Jackie Allen
America November 16, 2026
Sneaker Wave Nearly Sweeps Oregon Woman…

SECRET BEACH, Oregon — A peaceful day along Oregon’s rugged…

By – Jackie Allen
America November 16, 2026
Robert Pattinson Named New James Bond:…

LONDON — Robert Pattinson has been named the newest actor…

By – Jackie Allen
America November 16, 2026
Mystery Star System Transmits Radio Signals…

PERTH, Australia — Astronomers have discovered an unusual star system…

By – Jackie Allen
America November 16, 2026
U.S. Soldiers Googled Hospitals After Deadly…

WASHINGTON — U.S. soldiers used Google to find hospitals after…

By – Michallie K Harrison
America November 15, 2026
Hackers Hit America’s Drinking Water Systems…

ATLANTA – Hackers have crossed a dangerous line in America’s…

By – Samuel Lopez
America November 15, 2026
America Loses Its Measles-Free Status for…

WASHINGTON, D.C. — For the first time in a quarter…

By – Derek Johnson
America November 11, 2026
Brooklyn Building Collapse Kills 2 as…

A Brooklyn building collapse killed at least two people and…

By – Michallie K Harrison
America November 11, 2026
A Veterans Day Betrayal: House Advances…

OPINION | The Republican-led House marked Veterans Day by advancing…

By – Michallie K Harrison
America November 11, 2026
AI Godfather Warns of Chernobyl-Style Blackout…

By Samuel LĂłpez | USA Herald | November 11, 2026…

By – Samuel Lopez
America November 10, 2026
Vitamin K Deficiency Bleeding: Why the…

A single injection administered in the first hours of life…

By – Tyler Brooks
America November 15, 2026
Tower Hill Investment in Gator Athletics:…

The Tower Hill investment in Gator Athletics just rewrote the…

By – Tyler Brooks
America November 14, 2026
Golden State Valkyries Star Gabby Williams…

 Golden State Valkyries forward Gabby Williams believes Indiana Fever star…

By – Jackie Allen
America November 8, 2026
Dana White Reportedly Declines Trump White…

By Samuel Lopez – USA Herald | November 8, 2026…

By – Samuel Lopez
America November 7, 2026
Mike Tyson And Ric Flair Score…

Inside the $50 Million Legal Battle A federal judge rejected…

By – Samuel Lopez
America November 5, 2026
Dallas Cowboys Face  Crisis After Crushing…

By Jackie Allen | USA Herald The Dallas Cowboys are…

By – Jackie Allen
America November 4, 2026
WNBA: DeWanna Bonner Makes Emotional Admission…

ATLANTA — The WNBA Finals ended in heartbreak for the…

By – Jackie Allen

No posts found.

No posts found.

Signup for the USA Herald
exclusive Newsletter